Biomolecules and Biomedicine

BJBMS becomes Biomolecules and Biomedicine

We are excited to annouce the title change of BJBMS from January 2023.
Find out more about this change in our Blog story and Editorial.

New Impact Factor (2021) for BJBMS is 3.759

Journal Impact Factor for BJBMS has again risen by more than 11% over the last year.
Read about our new impact factor, performace metrics, and reviewers in a Blog story.

Latest articles

BJBMS continuously publishes highly relevant and trending articles in the Advanced online section.
Check out the list of the most recently published articles here.

COVID-19 Highlights

SARS-CoV-2 infection: Understanding the immune system abnormalities to get an adequate diagnosis

Karen Medina-Quero et al.
Read more

Molecular biology Highlights

Bionformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer

Ma et al.
Read more

COVID-19 Highlights

Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic – reports of three adolescents

Krasic et al.
Read more

Video article

Microsurgical resection of giant T11/T12 conus cauda equina schwannoma

Arnautovic A, Pojskic M, Arnautovic K
Read more

Review article

The role of glycogen synthase kinase 3 (GSK3) in cancer with emphasis on ovarian cancer development and progression: A comprehensive review

Mislav Glibo, Alan Serman, Valentina Karin-Kujundzic, et al.
Read more

Highlights

Cannabinoids in cancer treatment: Therapeutic potential and legislation

Barbara Daris, Mojca Tancer Verboten, Zeljko Knez, Polonca Ferk
Read more

Background Photo credits: Pixabay

Biomolecules and Biomedicine (formerly the Bosnian Journal of Basic Medical Sciences, BJBMS) is aimed at readers from a range of medical disciplines. The journal publishes articles in laboratory, translational, and clinical biomedicine, including Genetics and Molecular Biology, Immunology, Microbiology, Pathology, Biochemistry, Pharmacology, Anatomy, Biomaterials, New and Emerging Research and Diagnostic Methods, New and Emerging Medical Entities, and others.

Edited by: Muzafer Mujic, MD, PhD and Semir Vranic, MD, PhD
Journal Impact Factor® (2021): 3.759
5-year Journal Impact Factor®: 3.68
CiteScore® (2021): 5.2
ISSN: 2831-0896 (Print)
ISSN: 2831-090X (Online)
Open Access
Frequency: Continuously published online. Six printed issues per year.
Published by: The Association of Basic Medical Sciences of FBIH

> Journal indexing and metrics
> Why publish with us?

NEWS, ANNOUNCEMENTS AND HIGHLIGHTS

Announcements

The Reviewer of the Month for January 2023

2023-01-12

We proudly announce that the Reviewer of the Month Award for January 2023 goes to Jonathan Hinton, MD.

As a means to promote the hard work and dedication invested “behind the scenes” to improve scientific publications, each month, BiomolBiomed Editors select a reviewer who performed the best amongst all the reviewers in the current month. Selection is based on the quality, thoroughness, and timeliness of the review. It is a difficult task for our Editors, as they try not to underestimate the time and efforts of each of the reviewers who reviewed for the BiomolBiomed in the current month.

Current Issue

Vol. 23 No. 1 (2023)

Published: 2023-01-06

Editorial

Bosnian Journal of Basic Medical Sciences becomes Biomolecules and Biomedicine

Muzafer Mujić, Semir Vranić, Faruk Skenderi

1

Special Articles

Guidelines for breast cancer treatment in Bosnia and Herzegovina

Lejla Hadžikadić-Gušić, Timur Cerić, Inga Marijanović, Ermina Iljazović, Dijana Koprić, Anela Zorlak, Mahira Tanović, Alma Mekić-Abazović, Ibrahim Šišić, Una Delić, Jasminka Mustedanagić-Mujanović, Alija Aginčić, Edin Bećiragić, Frederick Greene

2-14